Biotech
-
-390x220.jpg)
Axovant buys more gene therapies, setting it up for a busy 2019
[ad_1] Axovant has licensed two gene therapies from the University of Massachusetts Medical School (UMMS). The deal accelerates Axovant’s evolution…
Read More » -
Extendicare Announces December 2018 Dividend of C$0.04 per Share Toronto Stock Exchange:EXE
[ad_1] MARKHAM, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) introduced that it…
Read More » -
CRISPR controls obesity in mice by amplifying rather than editing genes
[ad_1] The genes SIM1 and MC4R regulate food consumption by signaling the sensation of being full, which is why mutations…
Read More » -
Sunovion, PsychoGenics nondopamine schizophrenia drug meets phase 2 endpoint
[ad_1] Sunovion Pharmaceuticals and PsychoGenics unveiled constructive phase 2 outcomes for a brand new schizophrenia therapy that doesn’t bind to…
Read More » -
Nobel Prize-Winning Chemists: Misguided GMO Fears Could Hinder Technology’s Societal Benefits
[ad_1] On Friday, December 7, two winners of the 2018 Nobel prize for Chemistry – American chemical engineer Frances Arnold…
Read More » -
Deep Blue Med Spa Announces New Profound Procedure to Treat Wrinkles and Rejuvenate Jawline
[ad_1] LONG ISLAND, NY, Dec. 13, 2018 (GLOBE NEWSWIRE) — Deep Blue Med Spa, overseen by the plastic surgeons at…
Read More » -
Amag merges with Perosphere, adding NOAC antidote
[ad_1] Amag Pharma has struck a merger deal with Perosphere, adding an anticoagulant reversal agent in midstage trials to its…
Read More » -
-390x220.jpg)
NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients
[ad_1] NeuroRx is planning to maneuver NRX-101 into part 2b/3 after detecting indicators of efficacy in a feasibility trial in…
Read More » -
Biogen bails on AGTC after ocular gene therapy flunks trial
[ad_1] Applied Genetic Technologies’ $1 billion-plus gene therapy pact with Biogen has been torn up after their lead candidate failed…
Read More » -
Could a once-abandoned obesity drug be revived in osteoporosis?
[ad_1] Irisin, the as soon as much-hyped however controversial “exercise hormone” that researchers had hoped would be an efficient obesity…
Read More »
